New Zealand markets open in 10 hours

Spyre Therapeutics, Inc. (SYRE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
33.09+0.11 (+0.33%)
At close: 04:00PM EDT
33.09 0.00 (0.00%)
After hours: 04:01PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-0.95-0.96-3.93-3.89
Low estimate-1.21-1.25-5-5.35
High estimate-0.52-0.55-2.4-2.58
Year ago EPS-56.75-9.34-49.12-3.93
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5455
Avg. Estimate4MN/A8M6M
Low estimateN/AN/AN/AN/A
High estimate20MN/A40M30M
Year ago sales688kN/A886k8M
Sales growth (year/est)481.40%N/A802.90%-25.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-4.5-0.84-0.78-1.17
Actual EPS-56.75-9.34-4.05-1.2
Difference-52.25-8.5-3.27-0.03
Surprise %-1,161.10%-1,011.90%-419.20%-2.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.95-0.96-3.93-3.89
7 days ago-1.02-1.03-4.18-4.11
30 days ago-0.89-0.96-3.52-3.13
60 days ago-0.92-0.98-3.68-3.21
90 days ago-0.44-0.54-1.94-2.03
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days2222
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSYREIndustrySector(s)S&P 500
Current qtr.98.30%N/AN/AN/A
Next qtr.89.70%N/AN/AN/A
Current year92.00%N/AN/AN/A
Next year1.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A